+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Tissue Regenerative Materials - Medical Devices Pipeline Product Landscape, 2021

  • PDF Icon

    Report

  • 39 Pages
  • May 2021
  • Region: Global
  • GlobalData
  • ID: 5337968
The publisher's Medical Devices sector report, "Tissue Regenerative Materials - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Tissue Regenerative Materials pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Tissue Regenerative Material is a biomaterial component which facilitates regeneration of lost periodontal hard and soft tissue.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Tissue Regenerative Materials under development
  • the report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • the report reviews the major players involved in the development of Tissue Regenerative Materials and list all their pipeline projects
  • the coverage of pipeline products based on various stages of development ranging from Early development to Approved / Issued stage
  • the report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Tissue Regenerative Materials under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Tissue Regenerative Materials Overview
3 Products under Development
3.1 Tissue Regenerative Materials - Pipeline Products by Stage of Development
3.2 Tissue Regenerative Materials - Pipeline Products by Territory
3.3 Tissue Regenerative Materials - Pipeline Products by Regulatory Path
3.4 Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date
3.5 Tissue Regenerative Materials - Ongoing Clinical Trials
4 Tissue Regenerative Materials - Pipeline Products under Development by Companies
4.1 Tissue Regenerative Materials Companies - Pipeline Products by Stage of Development
4.2 Tissue Regenerative Materials - Pipeline Products by Stage of Development
5 Tissue Regenerative Materials Companies and Product Overview
5.1 Colorado Therapeutics, LLC Company Overview
5.1.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.2 credentis AG Company Overview
5.2.1 credentis AG Pipeline Products & Ongoing Clinical Trials Overview
5.3 Histocell SL Company Overview
5.3.1 Histocell SL Pipeline Products & Ongoing Clinical Trials Overview
5.4 Indian Institute of Technology Bombay Company Overview
5.4.1 Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview
5.5 Maxigen Biotech Inc Company Overview
5.5.1 Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Nobel Biocare Services AG Company Overview
5.6.1 Nobel Biocare Services AG Pipeline Products & Ongoing Clinical Trials Overview
5.7 Novatissue SAS Company Overview
5.7.1 Novatissue SAS Pipeline Products & Ongoing Clinical Trials Overview
5.8 Orthocell Ltd Company Overview
5.8.1 Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.9 Orthorebirth Co Ltd Company Overview
5.9.1 Orthorebirth Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.10 Polytechnic University of Catalonia Company Overview
5.10.1 Polytechnic University of Catalonia Pipeline Products & Ongoing Clinical Trials Overview
5.11 Straumann Holding AG Company Overview
5.11.1 Straumann Holding AG Pipeline Products & Ongoing Clinical Trials Overview
5.12 SurgaColl Technologies Ltd Company Overview
5.12.1 SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.13 SweetBio, Inc. Company Overview
5.13.1 SweetBio, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.14 Tigran Technologies AB Company Overview
5.14.1 Tigran Technologies AB Pipeline Products & Ongoing Clinical Trials Overview
5.15 Trimph Technology Pty Ltd Company Overview
5.15.1 Trimph Technology Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
6 Tissue Regenerative Materials- Recent Developments
6.1 Apr 29, 2021: First-quarter 2021 report Media Release
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Tissue Regenerative Materials - Pipeline Products by Stage of Development
  • Tissue Regenerative Materials - Pipeline Products by Territory
  • Tissue Regenerative Materials - Pipeline Products by Regulatory Path
  • Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date
  • Tissue Regenerative Materials - Ongoing Clinical Trials
  • Tissue Regenerative Materials Companies - Pipeline Products by Stage of Development
  • Tissue Regenerative Materials - Pipeline Products by Stage of Development
  • Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Xenograft Implant - Dental - Product Status
  • Xenograft Implant - Dental - Product Description
  • credentis AG Pipeline Products & Ongoing Clinical Trials Overview
  • CUROLOX Perio - Product Status
  • CUROLOX Perio - Product Description
  • Histocell SL Pipeline Products & Ongoing Clinical Trials Overview
  • HR018-Neofibrin - Product Status
  • HR018-Neofibrin - Product Description
  • Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview
  • Electrospun Scaffold - Product Status
  • Electrospun Scaffold - Product Description
  • Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
  • MaxiGuide - Product Status
  • MaxiGuide - Product Description
  • Nobel Biocare Services AG Pipeline Products & Ongoing Clinical Trials Overview
  • Bone Inductive Implant - Product Status
  • Bone Inductive Implant - Product Description
  • Novatissue SAS Pipeline Products & Ongoing Clinical Trials Overview
  • OrthoNovaOss - Product Status
  • OrthoNovaOss - Product Description
  • Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Striate+ - Product Status
  • Striate+ - Product Description
  • Orthorebirth Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • GCT-101 - Product Status
  • GCT-101 - Product Description
  • Polytechnic University of Catalonia Pipeline Products & Ongoing Clinical Trials Overview
  • Inorganic Dental Cement - Product Status
  • Inorganic Dental Cement - Product Description
  • Straumann Holding AG Pipeline Products & Ongoing Clinical Trials Overview
  • Soft Tissue Control Implant - Product Status
  • Soft Tissue Control Implant - Product Description
  • SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • DentaColl - Product Status
  • DentaColl - Product Description
  • SweetBio, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • SweetBio GTR (Guided Tissue Regeneration) Membrane - Product Status
  • SweetBio GTR (Guided Tissue Regeneration) Membrane - Product Description
  • Tigran Technologies AB Pipeline Products & Ongoing Clinical Trials Overview
  • Tigran Porous Titanium Granules - Alveolar Fillings - Product Status
  • Tigran Porous Titanium Granules - Alveolar Fillings - Product Description
  • Trimph Technology Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • TrimphDent - Product Status
  • TrimphDent - Product Description
  • Trimph Technology Pty Ltd - Ongoing Clinical Trials Overview
  • TrimphDent - PET-B: Post Extraction Use of Trimphdent Part B. A Comparator Controlled Clinical Investigation Comparing the Bone Healing Capability of the Investigational Product Trimphdent plus Biooss (TDB) and the Gold Standard of Care Comparator Bioosscollagen (Bioosscol), for Adults Who Have Been Treatment Planned for Tooth Extraction/S and Implant Placement at the Same Extraction Site/s
  • Glossary

List of Figures
  • Tissue Regenerative Materials - Pipeline Products by Stage of Development
  • Tissue Regenerative Materials - Pipeline Products by Territory
  • Tissue Regenerative Materials - Pipeline Products by Regulatory Path
  • Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Colorado Therapeutics, LLC
  • credentis AG
  • Histocell SL
  • Indian Institute of Technology Bombay
  • Maxigen Biotech Inc
  • Nobel Biocare Services AG
  • Novatissue SAS
  • Orthocell Ltd
  • Orthorebirth Co Ltd
  • Polytechnic University of Catalonia
  • Straumann Holding AG
  • SurgaColl Technologies Ltd
  • SweetBio, Inc.
  • Tigran Technologies AB
  • Trimph Technology Pty Ltd